OpenVSafe by OpenVAERS
Search V-safe

N9A-12633-61917

4 vaccinations 4 coded responses 36 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
626 / IL
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-07-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  15. 2021-10-01
    Health check-in — day 0, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  16. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  19. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2021-10-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  23. 2021-10-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-10-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-11-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-31
    Survey response — 3 months, dose 3
    MedDRA: COVID-19, Headache, Migraine — Feeling: Good · Be unable to do your normal daily activities
    Free text: I was COVID positive on 12/5/21. I also had a post-COVID headache for 12 days and a migraine.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-10-01
    Survey response — 12 months, dose 3
    MedDRA: Lymphadenopathy, Migraine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Axillary lymph node enlargement; frequent migraines
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-10-01
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2022-10-03
  31. 2022-10-24
    Dose 4 — Pfizer-BioNTech
  32. 2022-10-25
    Survey response — days 1–6 daily, dose 4
    MedDRA: Insomnia — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Trouble sleeping last night
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-10-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  34. 2022-10-27
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-10-29
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-10-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  37. 2022-11-02
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  38. 2022-11-07
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-11-15
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-11-30
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-12-05
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-01-25
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  43. 2023-04-26
    Survey response — 6 months, dose 4
    MedDRA: Cough, Eye pruritus, Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  44. 2023-04-26
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  45. 2023-04-27
  46. 2023-04-27

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-07Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No
42022-10-24Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: I was COVID positive on 12/5/21. I also had a post-COVID headache for 12 days and a migraine.

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: Axillary lymph node enlargement; frequent migraines

Release 12 — days 1–6 daily, dose 4

2022-10-25

Systemic reaction (other): Trouble sleeping last night

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDEye pruritus · · ✓
SDHeadache · · ✓
SDLacrimation increased · · ✓
SDLymphadenopathy · · ✓
SDMigraine · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓
SROInsomnia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release